Faringomed

General characteristics. Structure:

Active components: Phytolacca americana, Phytolacca (Poke americana (Poke)) C24, Atropa belladonna, Belladonna (Atropa belladonna (Belladonna)) C30, Hepar sulfuris (Gepar сульфурис) C12, Acidum silicicum, Silicea (Atsidum силициум (Силицеа)) C12.
Excipients: изомальт, sodium saccharin, sodium cyclomate, citric acid anhydrous, magnesium stearate.

Description:
Tablets of a ploskotsilindrichesky form with risky and a facet, from white till almost white color. On the flat party from risky MATERIA MEDICA text is put, on other flat party FARINGOMED text is put.

Pharmacological properties:

Has soothing and antiinflammatory effect. Reduces puffiness, reddening, feeling of irritation and a pharyngalgia, facilitates nasal breath, reduces probability of development of complications from ENT organs.

Indications to use:

Treatment of inflammatory diseases of a throat at adults and children is more senior than 5 years, including, as a part of complex therapy.

Route of administration and doses:

On reception one tablet is held in a mouth before full dissolution.
It is reasonable to begin administration of drug at emergence of the first symptoms of a disease.
Drug is accepted according to the following scheme: the first 2 hours of treatment - on 1 tablet each hour, then on 1 tablet each 3-4 hours, but no more than 5 tablets a day.
At preservation of the expressed disease symptoms within 24 hours from the moment of an initiation of treatment drug it is necessary to see a doctor.

Features of use:

Safety of use of Faringomed at pregnancy and in the period of a lactation was not studied. In need of administration of drug it is necessary to consider a ratio risk/advantage.

Side effects:

When using according to the specified indications in the specified dosages of side effect it is not revealed so far.
Reactions of the increased individual sensitivity to drug components are possible.

Interaction with other medicines:

Cases of incompatibility with other medicines are not registered so far.

Contraindications:

The increased individual sensitivity to drug components, children's age up to 5 years (owing to lack of experience of a clinical use).

Overdose:

At accidental overdose the dispeptic phenomena caused by the fillers which are a part of a dosage form are possible.

Storage conditions:

In the dry, protected from light place, at a temperature not above 25 °C. To store in the place, unavailable to children. Period of validity 3 years. Not to use upon termination of the period of validity specified on packaging.

Issue conditions:

Without recipe

Packaging:

Tablets for a rassasyvaniye. On 10 tablets in a blister strip packaging from a film of polyvinyl chloride and aluminum foil. On 1, 2 or 5 blister strip packagings together with the instruction on a medical use place in a pack from a cardboard.